1. Home
  2. SME IPO
  3. Infinium Pharmachem Ltd IPO
Infinium Pharmachem IPO

Infinium Pharmachem IPO

  • Status: Closed
  • RHP:
  • ₹ 135,000 / 1000 shares

    Minimum Investment

IPO Details

  • Open Date

    31 Mar 2023

  • Close Date

    05 Apr 2023

  • IPO Price Range

    ₹ 135

  • IPO Size

    ₹ 25.26 Cr

  • Listing Exchange

    NSE SME

  • Listing Date

    17 Apr 2023

With just a few clicks, Invest in IPO's!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Objective Financials SWOT FAQ Contacts

IPO Timeline

Infinium Pharmachem IPO Subscription Status

Last Updated: 03 January 2024 8:57 PM by 5Paisa

Infinium Pharmachem IPO opens on Mar 31, 2023, and closes on Apr 5, 2023. The issue entails fresh issue of 1,875,000 equity shares aggregating the issue size upto Rs. 25.31cr. The issue will be listed on SME NSE on 17th April while the shares will be allotted on 11th April. The company has set the lot size at 1000 shares per lot while the price is set at Rs. 135 per share. The leading book manager to the issue is Swatiska Investmart Ltd.

Objective of the Infinium Pharmachem IPO:

The net proceeds from the issue will be utilised towards:

1.    Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses)
2.    Repayment of some of the existing loans and expansion of units
3.    To meet incremental working capital requirements
4.    To meet public issue expenses
 

The Company was incorporated with the objective of manufacturing and supplying of various pharma related chemicals, bulk drugs, pharma intermediates etc. It deals specifically and mainly in manufacturing and supplying of Iodine Derivatives, Pharma Intermediates and Active Pharmaceutical Ingredients (APIs).

The Company penetrated the pharmaceutical market with the CRAMS Model i.e., Contract Research & Manufacturing Services in which the Company emphasizes on: 

1. Process Optimization

2. Developing / Manufacturing the products specifically as per customer's requirement and final application;

3. Customized Packing / Labelling

4. Reliable Supply of final product

5. Highly focused to Iodine Chemistry

The company’s manufacturing capabilities and technical expertise have efficiently catered numerous industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics and much more.

The Company currently provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs.

Check Out Web-Stories on Infinium Pharmachem IPO

Check Infinium Pharmachem IPO GMP (Grey Market Premium)

Check Infinium Pharmachem IPO GMP Webstories

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY22 FY21 FY20
Revenue from operations 99.12 70.53 38.84
EBITDA 9.64 5.53 3.20
PAT 6.11 2.72 0.93
Particulars (in Rs. Crores) FY22 FY21 FY20
Total Assets 59.00 34.18 22.45
Share Capital 1.02 1.02 1.02
Total Borrowings 13.85 5.79 5.66
Particulars (in Rs. Crores) FY22 FY21 FY20
Net cash generated from / (used in) operating activities 11.80 7.29 3.03
Net cash from / (used in) investing activities -6.63 -5.00 -1.05
Net cash flow from / (used in) financing activities -1.70 -1.16 -1.24
Net increase (decrease) in cash and cash equivalents 3.46 1.13 -1.24

Peer Comparison

Name of the Company

Revenue from operations (in Rs. crores)

 EBITDA PAT Margin Net Worth
Infinium Pharmachem Limited 74.04 9.64 7.43% 12.55
Samrat Pharmachem Limited 221.81 24.89 7.75% 46.82


Strengths

1.    Expanding reach to over 15+ countries across the globe while significantly increasing customer base in India too
2.    The Company has a good quantity of competent raw material suppliers, which allows it to bypass many supply-chain bottlenecks
3.    Professional and experience team including our in-house R&D and Quality Assurance departments
4.    Competitive marketing Strategy garnering consistent growth in revenue
 

Risks

1.    Domestic Sales are dependent on Top 5 States and export sales are majorly dependent on the China
2.    Manufacturing process involves the use of hazardous and flammable industrial chemicals which entails significant risks and could also result in enhanced compliance obligations
3.    reliant on third-party transportation service providers for the movement of raw materials and finished products
4.    Any inability to compete effectively may lead to a lower market share or reduced operating margins.
 

Will You Apply for Infinium Pharmachem IPO?

Yes No Maybe

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
footer_form

FAQs

The price for the Infinium Pharmachem IPO is set at Rs. 135 per share.

The Infinium Pharmachem IPO opens on 31st March and closes on 5th April.

The IPO comprises of fresh issue of 1,875,000 equity shares aggregating the issue size upto Rs. 25.31cr.

The allotment date of Infinium Pharmachem IPO is set for 11th April.

The Infinium Pharmachem IPO will be listed on on 17th April.

 The Infinium Pharmachem IPO lot size is 1000 shares. A retail-individual investor can apply for up to 1 lots (1000 shares or ₹135,000).

The net proceeds from the issue will be used for:


1.       Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses)

2.       Repayment of some of the existing loans and expansion of units

3.       To meet incremental working capital requirements

4.       To meet public issue expenses

To apply for the IPO, follow the steps given below

·         Login to your 5paisa account and select the issue in the current IPO section

·         Enter the number of lots and price at which you wish to apply for

·         Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange

Unistone Capital Private Limited is the book running lead managers to the issue.

Infinium Pharmachem IPO is promoted by Mr. Mayank Shah.